吸入式一氧化氮市場規模、佔有率、成長分析（按類型、產品類型、應用、濃度、產品、最終用戶和地區分類）—產業預測（2026-2033年）

全球吸入式一氧化氮市場規模預計在 2024 年達到 12.9 億美元，從 2025 年的 14 億美元成長到 2033 年的 25.7 億美元，在預測期（2026-2033 年）內複合年成長率為 7.9%。

除了對呼吸系統和心血管健康的益處外，一氧化氮還具有顯著的抗菌特性，並在維持多重器官存活和血管穩態方面發揮關鍵作用。吸入一氧化氮可透過擴張肺動脈來改善通氣/灌注比，促進動脈氧合，進而增加流向通氣良好肺部區域的血流。由於一氧化氮能夠改善血液循環、氧氣輸送和營養吸收，最終提高運動表現，因此在運動員中得到廣泛應用。主要產業參與者正密切關注醫藥和醫療分銷領域，並致力於開發關鍵氣體的管道連接。由於終端用戶需求不斷成長、人們對一氧化氮醫療應用的認知不斷提高、心血管和呼吸系統疾病患病率上升以及研發領域的進步，全球吸入一氧化氮市場預計將迎來顯著成長。

全球吸入式一氧化氮市場促進因素

全球吸入式一氧化氮市場的主要驅動力是呼吸系統疾病發生率的不斷上升。由於呼吸系統疾病持續影響全球相當大比例的人口，預計吸入式一氧化氮作為治療選擇的需求將會增加。空氣污染、菸草煙霧以及各種職業風險因素等環境因素會顯著損害呼吸系統健康，並增加此類疾病的可能性。此外，人口老化導致免疫反應減弱和肺功能自然衰退，使個體更容易患上呼吸系統疾病。這一趨勢表明，全球呼吸系統相關健康問題將持續增加。

限制全球吸入式一氧化氮市場的因素

由於監管方面的嚴格挑戰，全球吸入式一氧化氮市場面臨多重限制。製造商在產品核可前必須遵守眾多監管標準，這既耗時又昂貴，往往會延緩新治療方法的研發和上市。此外，不同醫療體系在定價和報銷方面的複雜性也構成了額外的障礙。企業必須與支付者進行複雜的談判以確保吸入式一氧化氮的報銷，同時也要參與衛生技術評估（HTA）。這使得新參與企業難以有效地應對激烈的競爭。

全球吸入式一氧化氮市場趨勢

全球吸入式一氧化氮市場正處於強勁成長期，其主要驅動力是氣喘和慢性阻塞性肺病（COPD）等呼吸系統疾病的日益流行，這些疾病嚴重影響患者的生活品質。吸菸率的上升和工業污染的加劇進一步惡化了這些疾病的症狀，導致這些慢性疾病的發生率上升。因此，由於吸入式一氧化氮在治療嚴重呼吸窘迫方面具有療效，因此人們對包括吸入式一氧化氮在內的有效治療方法的需求日益成長。隨著人們對吸入式一氧化氮在治療急慢性呼吸道疾病方面的益處認知不斷提高，該市場有望大幅擴張，以滿足受影響人口的迫切醫療需求。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球吸入式一氧化氮市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 兒童
• 成人版

全球吸入式一氧化氮市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 吸入式一氧化氮輸送系統
• 消耗品
• 一氧化氮鋼瓶
• 計量配件
• 其他

全球吸入式一氧化氮市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 新生兒呼吸護理
• 慢性阻塞性肺病（COPD）
• 急性呼吸窘迫症候群（ARDS）
• 結核病治療
• 瘧疾治療
• 其他

全球吸入式一氧化氮市場規模（按濃度和複合年成長率分類）（2026-2033 年）

• 100 ppm
• 800 ppm
• 其他

全球吸入式一氧化氮市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 一次性
• 系統

全球吸入式一氧化氮市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 門診治療中心
• 診所

全球吸入式一氧化氮市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Mallinckrodt Pharmaceuticals（United States）
• Key Developments
• Air Liquide Healthcare（France）
• VERO Biotech（United States）
• Getinge AB（Sweden）
• Beyond Air, Inc.（United States）
• SLE Ltd.（United Kingdom）
• Bellerophon Therapeutics（United States）
• International Biomedical（United States）
• NIOX Group plc（United Kingdom）
• BOC Healthcare（United Kingdom）
• Merck KGaA（Germany）
• Nu-Med Plus Inc.（United States）
• Perma Pure LLC（United States）
• HALMA PLC（United Kingdom）
• Matheson Tri-Gas Inc.（United States）
• Circassia Pharmaceuticals（United Kingdom）
• International Biomedical（United States）

結論與建議

Global Inhaled Nitric Oxide Market size was valued at USD 1.29 Billion in 2024 and is poised to grow from USD 1.4 Billion in 2025 to USD 2.57 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

Nitric oxide plays a vital role in supporting multiorgan survival and vascular homeostasis, with notable antibacterial properties alongside its benefits for respiratory and cardiovascular health. Inhaled nitric oxide enhances ventilation-perfusion matching and increases arterial oxygenation by dilating pulmonary arteries, thereby boosting blood flow to well-ventilated lung regions. Its use is popular among athletes for improving blood circulation, oxygen delivery, and nutrient absorption, ultimately enhancing exercise performance. Key industry players are focused on developing pipeline connections for essential gases, while monitoring distribution in the pharmaceutical and healthcare sectors. The global inhaled nitric oxide market is poised for significant growth, driven by increasing end-user demand, rising awareness of its healthcare applications, escalating rates of cardiovascular and respiratory conditions, and ongoing advancements in research and technology.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inhaled Nitric Oxide market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inhaled Nitric Oxide Market Segments Analysis

Global Inhaled Nitric Oxide Market is segmented by Type, Product Type, Application, Strength, Product, End-user and region. Based on Type, the market is segmented into Pediatric and Adult. Based on Product Type, the market is segmented into Inhaled Nitric Oxide Delivery Systems, Consumables, Nitric Oxide Cylinders, Delivery Accessories and Others. Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Tuberculosis Treatment, Malaria Treatment and Others. Based on Strength, the market is segmented into 100 ppm, 800 ppm and Others. Based on Product, the market is segmented into Disposables and System. Based on End-user, the market is segmented into Hospitals, Ambulatory Centers and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market is primarily propelled by the growing incidence of respiratory diseases. As respiratory disorders continue to affect a significant portion of the global population, the demand for inhaled nitric oxide as a therapeutic alternative is expected to rise. Environmental factors such as air pollution, tobacco smoke, and various occupational hazards contribute significantly to diminishing respiratory health, thus increasing the likelihood of developing such conditions. Additionally, the aging demographic, characterized by declining immune responses and natural alterations in lung function, renders individuals more susceptible to respiratory ailments. This trend suggests a continual rise in respiratory-related health issues worldwide.

Restraints in the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market faces several constraints due to stringent regulatory challenges. Manufacturers are obligated to comply with numerous regulatory standards before their products can be approved, which is both costly and time-intensive. This often results in delays in the development and launch of new treatments. Additionally, the complexities surrounding pricing and reimbursement across various healthcare systems create further hurdles. Companies must engage in intricate negotiations with payers to secure reimbursement for inhaled nitric oxide while also grappling with health technology assessments, making it difficult for new entrants to navigate the competitive landscape effectively.

Market Trends of the Global Inhaled Nitric Oxide Market

The Global Inhaled Nitric Oxide market is seeing a robust growth trajectory, driven largely by the rising prevalence of respiratory illnesses such as asthma and COPD, which significantly impair quality of life. The escalation in smoking rates and industrial pollution is further exacerbating symptoms and increasing the incidence of these chronic conditions. Consequently, there is a heightened demand for effective treatments, including inhaled nitric oxide, due to its therapeutic benefits in managing severe respiratory distress. As awareness grows regarding the advantages of inhaled nitric oxide in acute and chronic respiratory scenarios, the market is poised for substantial expansion, catering to the pressing healthcare needs of affected populations.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Inhaled Nitric Oxide Market Size by Type & CAGR (2026-2033)

• Market Overview
• Pediatric
• Adult

Global Inhaled Nitric Oxide Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Inhaled Nitric Oxide Delivery Systems
• Consumables
• Nitric Oxide Cylinders
• Delivery Accessories
• Others

Global Inhaled Nitric Oxide Market Size by Application & CAGR (2026-2033)

• Market Overview
• Neonatal Respiratory Treatment
• Chronic Obstructive Pulmonary Disease (COPD)
• Acute Respiratory Distress Syndrome (ARDS)
• Tuberculosis Treatment
• Malaria Treatment
• Others

Global Inhaled Nitric Oxide Market Size by Strength & CAGR (2026-2033)

• Market Overview
• 100 ppm
• 800 ppm
• Others

Global Inhaled Nitric Oxide Market Size by Product & CAGR (2026-2033)

• Market Overview
• Disposables
• System

Global Inhaled Nitric Oxide Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Centers
• Clinics

Global Inhaled Nitric Oxide Market Size & CAGR (2026-2033)

• North America (Type, Product Type, Application, Strength, Product, End-user)
  • US
  • Canada
• Europe (Type, Product Type, Application, Strength, Product, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product Type, Application, Strength, Product, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product Type, Application, Strength, Product, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product Type, Application, Strength, Product, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Mallinckrodt Pharmaceuticals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Air Liquide Healthcare (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VERO Biotech (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beyond Air, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SLE Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bellerophon Therapeutics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIOX Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BOC Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nu-Med Plus Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perma Pure LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HALMA PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matheson Tri-Gas Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Circassia Pharmaceuticals (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations